semaglutide glp-1 peptide A Review on Semaglutide: An Oral Glucagon-Like 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus | Diabetes Therapy Semaglutide – GLP-1 Weight Loss

JAMA Surg 2024;159:660-7.ArticlePubMedPMC 20

You will gain complete knowledge, which can help you understand this treatment more clearly, and make informative decisions

Work closely with your healthcare provider Healthcare providers play a critical role in helping patients overcome plateaus

Most patients report noticeable reductions in hunger and food cravings within 3-7 days of starting injections, even before any weight appears on the scale

A: According to clinical trial data and real-world reports: Initial weight loss (2-5 pounds): Often within first 2-4 weeks Noticeable changes (5-10% body weight): Typically 3-6 months Maximum results (15-20% body weight): Usually 12-18 months Weight loss is gradual and occurs throughout dose escalation and maintenance phases

This content is for informational and educational purposes only and does not replace medical advice, diagnosis, or treatment